Erlotinib (Tarceva®): A promising drug targeting epidermal growth factor receptor tyrosine kinase

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Erlotinib (Tarceva®): A promising drug targeting epidermal growth factor receptor tyrosine kinase'. Together they form a unique fingerprint.

Medicine & Life Sciences